Table 2 The relationship between Alb/dNLR ratio and clinicopathological parameters in patients with ESCC aged 60 years and above
Clinicopathological features | Alb/dNLR | χ2 | P | |
|---|---|---|---|---|
low(n = 99) | high(n = 229) | |||
Gender | ||||
Male | 71(33.2) | 143(66.8) | 2.620 | 0.106 |
Female | 28(24.6) | 86(75.4) | ||
Location | ||||
Upper | 7(31.8) | 15(68.2) | 0.089 | 0.956 |
Middle | 68(29.7) | 161(70.3) | ||
Lower | 24(31.2) | 53(68.8) | ||
Smoking history | ||||
No | 45(27.3) | 120(72.7) | 1.334 | 0.248 |
Yes | 54(33.1) | 109(66.9) | ||
Drinking history | ||||
No | 64(27.5) | 169(72.5) | 2.814 | 0.093 |
Yes | 35(36.8) | 60(63.2) | ||
Grade | ||||
G1 + G2 | 63(28.1) | 161(71.9) | 1.420 | 0.233 |
G3 | 36(34.6) | 68(65.4) | ||
Pathological T stage | ||||
T1 + T2 | 31(28.2) | 79(71.8) | 0.315 | 0.575 |
T3 + T4 | 68(31.2) | 150(68.8) | ||
Lymph node involvement | ||||
No | 53(28.3) | 134(71.7) | 0.699 | 0.403 |
Yes | 46(32.6) | 95(67.4) | ||
TNM staging | ||||
I+II | 52(27.1) | 140(72.9) | 2.111 | 0.146 |
III+IV | 47(34.6) | 89(65.4) | ||
Survival status | ||||
Live | 38(24.1) | 120(75.9) | 5.444 | 0.020* |
Deceased | 61(35.9) | 109(64.1) | ||